Results
1
-
1
of
1
Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells
,
Cancer Cell International
[DOI: 10.1186/1475-2867-13-32]